Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Patton Fund Management Inc.

Patton Fund Management Inc. trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 13.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,469 shares of the biotechnology company’s stock after selling 1,856 shares during the quarter. Axon Enterprise comprises 1.5% of Patton Fund Management Inc.’s investment portfolio, making the stock its 12th biggest holding. Patton Fund Management Inc.’s holdings in Axon Enterprise were worth $7,411,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Asset Dedication LLC boosted its holdings in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Insigneo Advisory Services LLC boosted its stake in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after buying an additional 22 shares in the last quarter. Menard Financial Group LLC grew its holdings in Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after acquiring an additional 24 shares during the period. PFG Investments LLC raised its position in Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after acquiring an additional 25 shares in the last quarter. Finally, Gladstone Institutional Advisory LLC lifted its holdings in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on AXON. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Finally, JMP Securities boosted their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $524.85.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last ninety days. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Trading Up 5.4 %

Axon Enterprise stock opened at $637.53 on Wednesday. The stock has a 50-day moving average price of $618.29 and a 200 day moving average price of $476.64. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The stock has a market cap of $48.61 billion, a PE ratio of 164.74, a P/E/G ratio of 6.09 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.